Florida HB 309: Rural Emergency Hospitals

Status: Laid on Table, companion bill(s) passed, see CS/SB 644 (Ch. 2024-201) (as of 2024-03-05)

State: Florida · Session: 2024 · Bill: HB 309

Subjects: social welfare, subject index

Sponsors: Select Committee on Health Innovation, Shoaf, Barnaby, Franklin, López, J., Rudman, Tant

Bill Text

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 1 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

A bill to be entitled 1
An act relating to controlled substances; amending s. 2
893.03, F.S.; excepting from the list of Schedule I 3
controlled substances certain xylazine animal drug 4
products approved by the United States Food and Drug 5
Administration and used for certain purposes; amending 6
s. 893.13, F.S.; providing criminal penalties and 7
requiring a mandatory minimum term of imprisonment if 8
a person sells, manufactures, or delivers or possesses 9
with intent to sell, manufacture, or deliver xylazine; 10
amending s. 893.135, F.S.; creating the offense of 11
trafficking in xylazine; providing criminal penalties 12
and requiring a mandatory minimum term of imprisonment 13
and fines based on the quantity of the controlled 14
substance involved in the offense; providing effective 15
dates. 16
17
Be It Enacted by the Legislature of the State of Florida: 18
19
Section 1. Effective July 1, 2026, paragraph (c) of 20
subsection (1) of section 893.03, Florida Statutes, is amended 21
to read: 22
893.03 Standards and schedules.—The substances enumerated 23
in this section are controlled by this chapter. The controlled 24
substances listed or to be listed in Schedules I, II, III, IV, 25

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 2 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

and V are included by whatever official, common, usual, 26
chemical, trade name, or class designated. The provisions of 27
this section shall not be construed to include within any of the 28
schedules contained in this section any excluded drugs listed 29
within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 30
Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 31
Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 32
Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 33
Anabolic Steroid Products." 34
(1) SCHEDULE I.—A substance in Schedule I has a high 35
potential for abuse and has no currently accepted medical use in 36
treatment in the United States and in its use under medical 37
supervision does not meet accepted safety standards. The 38
following substances are controlled in Schedule I: 39
(c) Unless specifically excepted or unless listed in 40
another schedule, any material, compound, mixture, or 41
preparation that contains any quantity of the following 42
hallucinogenic substances or that contains any of their salts, 43
isomers, including optical, positional, or geometric isomers, 44
homologues, nitrogen-heterocyclic analogs, esters, ethers, and 45
salts of isomers, homologues, nitrogen-heterocyclic analogs, 46
esters, or ethers, if the existence of such salts, isomers, and 47
salts of isomers is possible within the specific chemical 48
designation or class description: 49
1. Alpha-Ethyltryptamine. 50

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 3 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-51
oxazoline). 52
3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 53
4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 54
5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 55
6. Bufotenine. 56
7. Cannabis. 57
8. Cathinone. 58
9. DET (Diethyltryptamine). 59
10. 2,5-Dimethoxyamphetamine. 60
11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 61
12. DMT (Dimethyltryptamine). 62
13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 63
analog of phencyclidine). 64
14. JB-318 (N-Ethyl-3-piperidyl benzilate). 65
15. N-Ethylamphetamine. 66
16. Fenethylline. 67
17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 68
18. Ibogaine. 69
19. LSD (Lysergic acid diethylamide). 70
20. Mescaline. 71
21. Methcathinone. 72
22. 5-Methoxy-3,4-methylenedioxyamphetamine. 73
23. PMA (4-Methoxyamphetamine). 74
24. PMMA (4-Methoxymethamphetamine). 75

CS/CS/HB 309 2026

CODING: Words stricken are deletions; words underlined are additions.
hb309-02-c2
Page 4 of 49
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 76
26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 77
27. MDA (3,4-Methylenedioxyamphetamine). 78
28. JB-336 (N-Methyl-3-piperidyl benzilate). 79
29. N,N-Dimethylamphetamine. 80
30. Parahexyl. 81
31. Peyote. 82
32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 83
analog of phencyclidine). 84
33. Psilocybin. 85
34. Psilocyn. 86
35. Salvia divinorum, except for any drug product approved 87
by the United States Food and Drug Administration which contains 88
Salvia divinorum or its isomers, esters, ethers, salts, and 89
salts of isomers, esters, and ethers, if the existence of such 90
isomers, esters, ethers, and salts is possible within the 91
specific chemical designation. 92
36. Salvinorin A, except for any drug pr

View Florida HB 309 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.